Anteris Technologies Ltd. (AU:AVR) has released an update.
Anteris Technologies Ltd announces its Annual General Meeting (AGM) set for 29 May 2024, with a call for Director nominations by 15 April 2024. The company, a pioneer in structural heart medical devices, is making strides with its groundbreaking DurAVRTM transcatheter heart valve, leveraging their patented ADAPT® anti-calcification technology, and is committed to advancing treatments for heart disease patients globally.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.
